Evome Medical Technologies Inc.
LNDZF
$0.0041
-$0.0027-39.71%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -389.35% | -7.27% | 12.43% | 21.25% | 70.61% |
| Total Depreciation and Amortization | -41.11% | 22.09% | 67.57% | 102.04% | 137.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,102.66% | 19.03% | -38.24% | -38.16% | -85.76% |
| Change in Net Operating Assets | 384.37% | 158.58% | 376.37% | 32.29% | -40.47% |
| Cash from Operations | 1,133.12% | 192.38% | -20.51% | 13.93% | 83.08% |
| Capital Expenditure | 95.51% | 87.27% | 82.23% | 73.59% | -264.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.00% | 74.71% | 77.34% | 78.61% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -177.24% |
| Cash from Investing | 98.84% | 98.57% | 76.91% | 77.92% | 71.15% |
| Total Debt Issued | -130.45% | -168.31% | -202.77% | -- | -60.53% |
| Total Debt Repaid | -538.20% | -58.46% | 97.06% | 83.87% | -310.38% |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | -99.24% | -99.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 2,283.10% |
| Cash from Financing | -88.40% | -458.77% | -37.66% | 0.26% | -151.75% |
| Foreign Exchange rate Adjustments | 342.55% | 74.01% | 2,653.62% | 644.99% | 65.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.25% | 97.09% | 58.85% | 85.90% | 12.75% |
